Short answer
IRONWOOD PHARMACEUTICALS INC (IRWD) filed an 8-K current report with the SEC on June 15, 2026 reporting Item 8.01 (Other Events). $200.0 million 1.50% convertible notes repaid at scheduled maturity on June 15, 2026.
IRONWOOD PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- $200.0 million 1.50% convertible notes repaid at scheduled maturity on June 15, 2026
- Repayment funded entirely with available cash, reducing debt but lowering cash reserves
- No noteholder conversions, avoiding potential equity dilution
- Related capped call transactions terminated upon note maturity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other IRONWOOD PHARMACEUTICALS INC 8-K filings
Get the next IRWD 8-K as it lands
Follow IRWD for push alerts, or ask the research agent what this filing means.